rethinkPeptides Search
Menu
Study breakdown

AI/ML for Predicting Migraine Treatment Response: A Scoping Review

evidence
The takeaway

AI/ML models show promise for predicting individual migraine treatment response, potentially enabling precision medicine instead of trial-and-error prescribing for anti-CGRP and other therapies.

Precision prescribing

AI could predict which migraine treatment works for each patient, replacing the current trial-and-error approach

What the researchers found

AI/ML models can predict migraine treatment response with varying accuracy, potentially enabling precision prescribing for anti-CGRP therapies and other migraine drugs, though validation and standardization are needed.

Why it matters

Moving from trial-and-error to precision migraine prescribing could reduce patient suffering and healthcare costs by getting the right treatment right the first time.

How the study worked

Scoping review of AI/ML studies predicting pharmacological treatment response in migraine, covering clinical, imaging, genetic, and biomarker prediction features.

What this study cannot tell us

Most studies have small datasets. External validation rare. No standardized treatment response definitions. Heterogeneous AI/ML methods.

How to read the evidence

Scoping review of an emerging field. Individual studies vary in quality; the field needs standardization and larger validation studies.

When this study was published

Published in 2025.

The bigger picture

Precision medicine for migraine could transform how anti-CGRP drugs and other treatments are prescribed, reducing the current 50%+ non-responder rate.

Questions still open

  • Which features best predict anti-CGRP drug response?
  • Can a unified prediction tool be deployed in clinical practice?
  • Would treatment prediction reduce overall migraine healthcare costs?

Common questions

Could AI predict which migraine drug will work for me?
Research is moving in that direction. AI models can analyze your clinical data, imaging, and genetics to predict which treatment is most likely to work, but these tools are not yet ready for routine clinical use.
Why is migraine treatment so often trial-and-error?
Everyone's migraine biology is slightly different, and we don't yet have reliable tests to match patients to treatments. AI could solve this by finding patterns in data that predict individual treatment responses.

Read the original research

Predicting Pharmacological Treatment Response in Migraine Using AI/ML: A Scoping Review of the Evidence and Future Directions.

Pharmacotherapy, 46(2), e70085

Citation

Giacon, Martina; Terrazzino, Salvatore. (2026). Predicting Pharmacological Treatment Response in Migraine Using AI/ML: A Scoping Review of the Evidence and Future Directions.. Pharmacotherapy, 46(2), e70085. https://doi.org/10.1002/phar.70085